Contemporary Review of Olfactory Dysfunction in COVID-19

The pandemic of coronavirus disease 2019 (COVID-19) is an extreme threat to international health care, resulting in more than two million deaths. Data reveal that olfactory disorder is a characteristic symptom of COVID-19 and has unique clinical manifestations. The olfactory dysfunction induced by COVID-19 has sudden onset, short duration, and rapid recovery, with anosmia often the only symptom. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) affects the human body by binding to angiotensin converting enzyme 2 (ACE2) of the olfactory epithelium. However, the etiology of COVID-19-induced olfactory dysfunction is unclear. In many countries, vaccines for COVID-19 in human are beginning to be administered. Conventional conservative treatments are common for olfactory disorders caused by COVID-19. Rhinologists should be aware of olfactory dysfunction to avoid delayed diagnosis of COVID-19. The article reviews the latest scientific evidence of anosmia in COVID-19..

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:28

Enthalten in:

Journal of Rhinology - 28(2021), 2, Seite 73-80

Sprache:

Englisch ; Koreanisch

Beteiligte Personen:

Hwae-Joon Jung [VerfasserIn]
Heung-Man Lee [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.j-rhinology.org [kostenfrei]
Journal toc [kostenfrei]
Journal toc [kostenfrei]

Themen:

Coronavirus
Covid-19
Etiology
Medicine
Olfaction disorders
Otorhinolaryngology
Physiopathology
R

doi:

10.18787/jr.2020.00346

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ015894649